Market review of over the counter drugs and health care products in China's retail channels in the third quarter of 2015

Source: Hermes 2016-02-23 overall market performance as the most important product in China's retail drugstore channel circulation, over-the-counter drugs and health food in the third quarter of 2015, the retail drugstore channel mat sales * has reached RMB 63 billion (data source: imspharmatrend Gamma National data for the third quarter of 2015) Compared with the same period last year, the sales volume showed an upward trend, but the sales volume decreased Among them, mat sales of over-the-counter drugs in the third quarter of 2015 was 52.8 billion yuan, with a growth rate of 9.2% The increase of average drug price is the main driving factor of this round of growth Chinese patent medicine continues to occupy more than 65% of the over-the-counter drug market with a growth rate of 11.4% mat But the western medicine market is still weak, and mat growth rate is 5.2% Sales amount *: retail drugstore purchase amount mat (rolling annual data) *: the total data retroactive for 12 months from the specified time node, which refers to the sales amount from July 2014 to June 2015 Market performance of multinational enterprises and domestic enterprises from IMS pharmatrend Gamma According to the market performance of the 40 core cities monitored, the market contribution mainly comes from domestic enterprises (86%), and the growth rate of mat in the third quarter of 2015 was 11.4%, with the main camp concentrated in the third and fourth tier cities and other small and medium-sized cities The main sales of multinational enterprises are still concentrated in the first and second tier cities, with a slight increase of 1.3% The high growth of domestic enterprises is mainly due to Chinese patent medicine No matter in price or sales volume, the market share of Chinese patent medicine of domestic enterprises has exceeded 50%, and the sales volume has increased as high as 11.8% From a provincial perspective, the mat10 provinces * in the third quarter of 2015 accounted for 61% of the national market, with Guangdong leading the market with 19% market share Domestic enterprises have contributed more than 80% market share in each province Multinational enterprises and domestic enterprises have different market emphasis on provinces The market share of Western medicine products of multinational enterprises is the highest in Jiangsu and Liaoning provinces, while the market share of domestic Chinese patent medicine is the highest in Zhejiang Province 10 provinces *: Guangdong, Sichuan, Jiangsu, Henan, Liaoning, Hunan, Zhejiang, Shandong, Hubei, Hebei over-the-counter medicine and health food markets are highly concentrated markets The top 20 manufacturers occupy 27% of the market share, of which only 5 are multinational companies, accounting for 6.8% of the market share The rest are domestic enterprises With a strong mat growth rate of 25%, Mr Thomson is ranked first in sales Wyeth maintains the first and third market position of multinational enterprises with 9.2% mat growth In the third quarter of 2015, the top 20 manufacturers of over-the-counter drugs + health care products ranked the top 20 manufacturers of over-the-counter drugs and health care products, with a growth rate of% 1, 25% 2, 31.5% 3, Wyeth 9.2% 4, Bayer 0.5% 5, Yunnan Baiyao 9.8% 6 Xi'an yangsen-1.3% 7 Jilin revision6.6% 8 Shandong Fujiao 61.2% 9 Kyoto nianci'an-3.2% 10 Jiangxi Jiangzhong pharmaceutical 19.5% 11 Jiangxi Huiren pharmaceutical 129.7% 12 Tongrentang technology 15.5% 13 Sanjiu pharmaceutical -5.3% 14 Guangzhou Chen Liji 99% 15 Henan Wanxi pharmaceutical 18.9% 16 Chongqing Fuling pharmaceutical 8.4% 17 Tianjin Shike - 14.4% 18 Hongmao pharmaceutical 22.8% 19 Guangzhou Longli trade - 17.3% 20 Harbin Pharmaceutical Sanjing - 9.1% data source:《 According to the national data of IMS pharmatrend tmnational audit, in the third quarter of 2015, the market performance of main categories and products in general, the "cough, cold and other respiratory system treatment" is still the largest category in China's retail drugstores, followed by "vitamin, mineral and nutritional supplement", followed by "vitamin, mineral and nutritional supplement" "Analgesia" However, the growth rate of mat in the category of "cough, cold and other respiratory treatment" is relatively slow, which is 1.7%, 8.3% in the category of "vitamin, mineral and nutrition supplement", and 18.1% in the category of analgesia, which is higher than the overall market Although the market share of "tonics and other stimulants" is small, the growth rate is the fastest, 38.9%, mainly due to the price growth of donkey hide gelatin products In terms of product ranking, its overall performance is also consistent with the overall market and category performance: · among the top 20 products, there are 12 Chinese patent medicine products, 6 western medicine products, and only 4 health care products Products are from multinational enterprises, others are products of domestic enterprises, and the overall growth rate of products of domestic enterprises is far greater than that of multinational enterprises (29.5% and 1.3% respectively) · vitamin, mineral, nutritional supplement and analgesic products are the most, 6 and 4 respectively Shandong dong'a-jiao's rolling sales data of donkey hide gelatin products ranked first in the whole year, and mat growth rate also reached 28.5% Huishi's calcium Erqi and Shandong Fujiao's donkey hide gelatin products follow closely List of 40 cities *: first tier cities: Beijing, Shanghai, Guangzhou, Shenzhen second tier cities: Tianjin, Chongqing, Hangzhou, Nanjing, Shenyang, Wuhan, Chengdu, Foshan, Dalian, Jinan, Xi'an, Harbin, Changsha, Ningbo, Qingdao, Wuxi Third tier cities: Zhengzhou, Dongguan, Taiyuan, Hefei, Nanning, Fuzhou, Nanchang, Shijiazhuang, Hohhot, Changzhou, Xuzhou, Wenzhou, Guiyang, Huai'an, Linyi, Taizhou, Yantai, Weifang fourth tier cities: Huizhou, Yichang in the third quarter of 2015, the top 20 non prescription drugs + health products manufacturers mat Growth rate% 1 Ejiao Shandong Dong Ejiao 28.5% 2 calq Wyeth 3.2% 3 Ejiao Shandong Fujiao 61.1% 4 Chuanbei Pipa cream Kyoto nianci'an-2.4% 5 Shenbao Jiangxi Huiren 145.2% 6 Tangchen Beijian protein powder Tangshen Beijian 18.9% 7 Hongmao pharmaceutical wine Hongmao pharmaceutical 22.8% 8 Shancun Huishi 4.3% 9 Shujin Jianyao pills Guangzhou Chen Liji 132.1% 10 diqiaoanshi pharmaceutical 0.8% 11 compound donkey hide gelatin paste Shandong Dong'e gelatin 79.4% 12 Jianwei Xiaoshi tablet Jiangzhong pharmaceutical 9.6% 13 Yunnan Baiyao Yunnan Baiyao - 2.8% 14 Tangshen Beijian liquid calcium Tangshen Beijian 15.2% 15 Sanjiu Ganmaoling Sanjiu pharmaceutical - 7.2% 16 sapais Zhejiang Pinghu sapais pharmaceutical 10.1% 17 Yixin dehumidification Zhitong Capsule Xi'an afanggong pharmaceutical - 9.3% 18 icoxin Shandong dyne marine biopharmaceutical 9.7% 19 zinc calcium Aonuo pharmaceutical 11.2% 20 Huoxiang Zhengqi Chongqing Fuling pharmaceutical 27% data source: IMS China retail drugstore statistical report (IMS Pharmatrend tmnational audit), Q3 2015